Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call highlights a 5% revenue increase and a 20% net income growth, indicating strong financial performance. Improved operating margin and cash flow further support a positive outlook. Despite forward-looking statements being subject to risks, the overall financial health and strategic focus on core growth areas like military and healthcare suggest optimism. The absence of negative Q&A feedback reinforces the positive sentiment, predicting a 2% to 8% stock price increase.
Revenue Revenue for Q4 2025 was $150 million, a 5% increase year-over-year, driven by higher enrollment rates and improved pricing strategies.
Operating Margin Operating margin stood at 12%, up from 10% in the previous year, reflecting better cost management and operational efficiencies.
Net Income Net income was $18 million, a 20% increase year-over-year, attributed to revenue growth and reduced operational costs.
Cash Flow Cash flow from operations was $25 million, a 15% increase year-over-year, due to improved collections and lower capital expenditures.
The selected topic was not discussed during the call.
Forward-looking statements: Subject to risks and uncertainties that could cause actual results to differ materially from expectations, including those identified in the company's Form 10-K under the heading Risk Factors.
Strategic Initiatives: Statements made during this call and in the accompanying presentation regarding APEI and its subsidiaries that are not historical facts may be forward-looking statements that are based on management's current expectations, assumptions, estimates and projections.
Forward-looking Statements: Statements made during this call and in the accompanying presentation regarding APEI and its subsidiaries that are not historical facts may be forward-looking statements that are based on management's current expectations, assumptions, estimates and projections. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements, such as those identified in our Form 10-K under the heading Risk Factors.
The selected topic was not discussed during the call.
The earnings call highlights a 5% revenue increase and a 20% net income growth, indicating strong financial performance. Improved operating margin and cash flow further support a positive outlook. Despite forward-looking statements being subject to risks, the overall financial health and strategic focus on core growth areas like military and healthcare suggest optimism. The absence of negative Q&A feedback reinforces the positive sentiment, predicting a 2% to 8% stock price increase.
The earnings call revealed mixed sentiments. Strong enrollment growth and positive guidance for adjusted EBITDA and free cash flow are countered by a projected net loss in Q3 and concerns about APUS registration declines. Cost-saving measures and a lack of specific details on capacity growth and future profit impacts add uncertainty. Overall, the neutral sentiment reflects balanced positive and negative factors, with no clear catalyst for significant stock movement.
The earnings call shows strong financial metrics, such as increased EBITDA, cash flow, and unrestricted cash. Despite some negative aspects like reduced Graduate School revenue and unclear military funding distribution, the overall sentiment is positive. The consolidation plan, breakeven status of Rasmussen and Hondros, and increased guidance for EBITDA and net income further support this view. The Q&A reveals potential growth through consolidation and military enrollments, although some management responses lacked clarity. Overall, the positive aspects outweigh the negatives, suggesting a likely stock price increase.
The earnings call reveals strong financial performance with increased revenue, EBITDA, and cash flow, alongside strategic initiatives like the consolidation of institutions and redemption of preferred shares. Despite some operational risks and unclear guidance on certain aspects, the overall sentiment is positive due to improved profitability and strategic cost reductions. The anticipated savings from preferred share redemption and asset sales further bolster this outlook, suggesting a likely positive stock reaction.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.